Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004). Due to its chronic and relapsing nature, atopic dermatitis presents a global public health concern, with reported lifetime prevalence ranging between 10%–20% in children and 1%–3% in adults (Larsen and Hanifin, 2002). In general, the prevalence of atopic dermatitis is increasing worldwide, with high prevalence in western and developed nations compared with other parts of the world. However, recent trends demonstrate a gradual rise in prevalence in developing countries and plateauing prevalence in developed countries (Asher et al., 2006). Although atopic dermatitis is not life-threatening, it has a huge impact on economic burden and quality of life of individuals (Carroll et al., 2005).
To Read The Complete Report with TOC : www.marketresearchreports.biz/analysis-details/epicast-report-atopic-dermatitis-epidemiology-forecast-to-2022
GlobalData’s epidemiological analysis forecasts that prevalent cases of atopic dermatitis in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India) will increase from 132.28 million in 2012 to 132.71 million cases in 2022 at an annual growth rate (AGR) of 0.10%. In 2012, China and India combined contributed 83.04 million cases, comprising more than 60% of the total prevalent cases in the 9MM.
GlobalData’s epidemiological forecast projects a substantial increase in the lifetime prevalent cases of atopic dermatitis in the 9MM over the forecast period (2012–2022). As GlobalData epidemiologists used steady prevalence proportions of atopic dermatitis over the forecast period, the growth in prevalent cases in each market can be attributed to the change in population demographics in the respective markets, especially in the younger age groups as they comprise the highest proportion of the prevalent cases.
The forecast underscores the considerable psychosocial and economic burden inflicted by atopic dermatitis particularly among children. Governments in the respective markets should develop strategies to tackle the growing problem and direct appropriate interventions towards reducing various triggers inducing atopic dermatitis especially among young children (Williams et al., 2012).
- The Atopic Dermatitis EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of atopic dermatitis in the 9MM. It includes a 10-year epidemiology forecast of atopic dermatitis prevalent cases segmented by age (in five-year increments beginning at age 0 and ending at ages 85 years and older), sex, and severity (mild, moderate, and severe) in the 9MM.
To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/169914
Reasons To Buy
- Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market.
- Quantify patient populations in the global atopic dermatitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for atopic dermatitis therapeutics in each of the markets covered.
- Identify the percentage of atopic dermatitis prevalent cases that are mild, moderate, and severe.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948